Skip to content
Search

Latest Stories

More people turning to community pharmacies as GP waiting times surge

More people turning to community pharmacies as GP waiting times surge

Sustainable funding is vital to ensure that community pharmacies can remain open and continue to provide much-needed care to patients and communities

People in the UK are increasingly relying on community pharmacies for health advice and support as they are unable to access their general practitioner (GP).


According to a recent report by the Liberal Democrats, there was a significant increase in the number of patients waiting four weeks or more to see a GP in England last year, rising from 12.8 million in 2022 to 17.6 million.

Responding to this research report, the Royal College of General Practitioners (RCGP) highlighted that GPs are also struggling to meet the increasing demand for their services due to severe staff shortages.

Dr. Victoria Tzortziou-Brown, Vice Chair of the RCGP, stated that the average number of patients each GP is responsible for has increased by 158 compared to five years ago.

Although she acknowledged that many patients are forced to wait for weeks to see their GP, she said that doctors too are grappling with “unmanageable and unsustainable workloads” and “we can’t keep doing more with less.”

There’s a growing reliance on community pharmacies for patient care amid difficulty accessing GP services.

Janet Morrison, Chief Executive of Community Pharmacy England (CPE), said: “Since the COVID-19 pandemic, people have really struggled to access their GP, with the morning rush for appointments all too familiar. They have come to rely upon community pharmacies who stayed open and accessible for health information and advice.”

The PSNC Pharmacy Advice Audit 2022 report indicated that as many as a quarter of a million people visited community pharmacies every week because they were unable to access other parts of the NHS.

Almost half of patients reported that if they did not have easy access to a pharmacy, they would have visited their GP, which would have resulted in an additional 619,000 appointments per week.

Based on these figures, the committee estimated that 32.2 million GP appointments per year could be avoided if patients had access to their local community pharmacy.

“This is why the Primary Care Recovery Plan announced the investment in the Pharmacy First service for common ailments – with the goal of freeing up 10 -12 million GP appointments a year,” Morrison said.

Launched on January 31 this year, the new scheme allows patients to get treatment and medicines from their local pharmacy for seven common conditions, including sinusitis, sore throat, earache, infected insect bite, impetigo, shingles, and uncomplicated urinary tract infections in women, without needing to see a GP.

Morrison added that they have already heard “very positive feedback” from patients about the care they’ve received and the relief of being able to access the help they need in one place.

However, she emphasised the need for sustainable underlying funding to enable the pharmacies “to stay open and continue to provide much-needed care to patients and communities.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less